Thomas Dienemann1, Susan L Ziolkowski2, Shaun Bender3, Simin Goral4, Jin Long5, Joshua F Baker6, Justine Shults7, Babette S Zemel8, Peter P Reese9, F Perry Wilson10, Mary B Leonard11. 1. Department of Surgery, University Hospital of Regensburg, Regensburg, Germany. Electronic address: thomas.dienemann@ukr.de. 2. Department of Medicine, Stanford University School of Medicine, Stanford, California. 3. Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut. 4. Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. 5. Department of Pediatrics, Stanford University School of Medicine, Stanford, California. 6. Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania. 7. Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. 8. Department of Pediatrics, The Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. 9. Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. 10. Department of Medicine, Yale University School of Medicine, New Haven, Connecticut. 11. Department of Medicine, Stanford University School of Medicine, Stanford, California; Department of Pediatrics, Stanford University School of Medicine, Stanford, California.
Abstract
RATIONALE & OBJECTIVE: Low muscle mass relative to fat mass (relative sarcopenia) has been associated with mortality and disability but has not been examined after kidney transplantation. We studied how measures of body composition change after receipt of a kidney allograft. STUDY DESIGN: Prospective longitudinal cohort study. SETTING & PARTICIPANTS: 60 kidney transplant recipients, aged 20-60 years, at the University of Pennsylvania. EXPOSURE: Kidney transplantation. OUTCOME: Dual-energy x-ray absorptiometry measures of fat mass index (FMI) and appendicular lean mass index (ALMI, representing muscle mass), computed tomography measures of muscle density (low density represents increased intramuscular adipose tissue), dynamometer measures of leg muscle strength, and physical activity. ALMI relative to FMI (ALMFMI) is an established index of relative sarcopenia. ANALYTICAL APPROACH: Measures expressed as age, sex, and race-specific z scores for transplant recipients were compared with 327 healthy controls. Regression models were used to identify correlates of change in outcome z scores and compare transplant recipients with controls. RESULTS: At transplantation, ALMI, ALMIFMI, muscle strength, and muscle density z scores were lower versus controls (all P≤0.001). Transplant recipients received glucocorticoids throughout. The prevalence of obesity increased from 18% to 45%. Although ALMI increased after transplantation (P<0.001) and was comparable with the controls from 6 months onward, gains were outpaced by increases in FMI, resulting in persistent ALMIFMI deficits (mean z score of-0.31 at 24 months; P=0.02 vs controls). Muscle density improved after transplantation despite gains in FMI (P=0.02). Muscle strength relative to ALMI also improved (P=0.04) but remained low compared with controls (P=0.01). Exercise increased in the early months after transplantation (P<0.05) but remained lower than controls (P = 0.02). LIMITATIONS: Lack of muscle biopsies precluded assessment of muscle histology and metabolism. CONCLUSIONS: The 2-year interval after kidney transplantation was characterized by gains in muscle mass and strength that were outpaced by gains in fat mass, resulting in persistent relative sarcopenia.
RATIONALE & OBJECTIVE: Low muscle mass relative to fat mass (relative sarcopenia) has been associated with mortality and disability but has not been examined after kidney transplantation. We studied how measures of body composition change after receipt of a kidney allograft. STUDY DESIGN: Prospective longitudinal cohort study. SETTING & PARTICIPANTS: 60 kidney transplant recipients, aged 20-60 years, at the University of Pennsylvania. EXPOSURE: Kidney transplantation. OUTCOME: Dual-energy x-ray absorptiometry measures of fat mass index (FMI) and appendicular lean mass index (ALMI, representing muscle mass), computed tomography measures of muscle density (low density represents increased intramuscular adipose tissue), dynamometer measures of leg muscle strength, and physical activity. ALMI relative to FMI (ALMFMI) is an established index of relative sarcopenia. ANALYTICAL APPROACH: Measures expressed as age, sex, and race-specific z scores for transplant recipients were compared with 327 healthy controls. Regression models were used to identify correlates of change in outcome z scores and compare transplant recipients with controls. RESULTS: At transplantation, ALMI, ALMIFMI, muscle strength, and muscle density z scores were lower versus controls (all P≤0.001). Transplant recipients received glucocorticoids throughout. The prevalence of obesity increased from 18% to 45%. Although ALMI increased after transplantation (P<0.001) and was comparable with the controls from 6 months onward, gains were outpaced by increases in FMI, resulting in persistent ALMIFMI deficits (mean z score of-0.31 at 24 months; P=0.02 vs controls). Muscle density improved after transplantation despite gains in FMI (P=0.02). Muscle strength relative to ALMI also improved (P=0.04) but remained low compared with controls (P=0.01). Exercise increased in the early months after transplantation (P<0.05) but remained lower than controls (P = 0.02). LIMITATIONS: Lack of muscle biopsies precluded assessment of muscle histology and metabolism. CONCLUSIONS: The 2-year interval after kidney transplantation was characterized by gains in muscle mass and strength that were outpaced by gains in fat mass, resulting in persistent relative sarcopenia.
Authors: Eugénie C H van den Ham; Jeroen P Kooman; Annemie M W J Schols; Fred H M Nieman; Joan D Does; Frits M E Franssen; Marco A Akkermans; Paul P Janssen; Johannes P van Hooff Journal: Am J Transplant Date: 2005-08 Impact factor: 8.086
Authors: Biruh Workeneh; Linda W Moore; Joy V Nolte Fong; Roman Shypailo; A Osama Gaber; William E Mitch Journal: J Ren Nutr Date: 2019-03-07 Impact factor: 3.655
Authors: Joshua F Baker; Matthew Davis; Ruben Alexander; Babette S Zemel; Sogol Mostoufi-Moab; Justine Shults; Michael Sulik; Daniel J Schiferl; Mary B Leonard Journal: Bone Date: 2012-12-11 Impact factor: 4.398
Authors: Alyssa B Dufour; Marian T Hannan; Joanne M Murabito; Douglas P Kiel; Robert R McLean Journal: J Gerontol A Biol Sci Med Sci Date: 2012-04-13 Impact factor: 6.053
Authors: Bret H Goodpaster; Peter Chomentowski; Bryan K Ward; Andrea Rossi; Nancy W Glynn; Matthew J Delmonico; Stephen B Kritchevsky; Marco Pahor; Anne B Newman Journal: J Appl Physiol (1985) Date: 2008-09-25
Authors: Matthew J Delmonico; Tamara B Harris; Jung-Sun Lee; Marjolein Visser; Michael Nevitt; Stephen B Kritchevsky; Frances A Tylavsky; Anne B Newman Journal: J Am Geriatr Soc Date: 2007-05 Impact factor: 5.562
Authors: Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy Journal: Am J Epidemiol Date: 2002-11-01 Impact factor: 4.897
Authors: Tássia Louise Sousa Augusto de Morais; Karla Simone Costa de Souza; Mabelle Alves Ferreira de Lima; Maurício Galvão Pereira; José Bruno de Almeida; Antônio Manuel Gouveia de Oliveira; Karine Cavalcanti Mauricio Sena-Evangelista; Adriana Augusto de Rezende Journal: PLoS One Date: 2022-08-04 Impact factor: 3.752